To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Below are listed all the projects of the 7th European Framework Program (FP7) of which the institute is a partner or even a coordinator. 3 great areas are affected: health, biotechnology and nanoscience.
Using current best practice against biotoxins, the EuroBioTox core members will develop and validate improved analytical tools, reagents and standard operating procedures based on realistic incident scenarios. Certified Reference Materials will be developed against this threat and, by establishing a European repository, will be made available to the EuroBioTox network including more than 50 European organisations.
PEVIA consortium aims to develop a new generation of vaccines against multiple Ebola virus strains, easy to produce and to deploy in the endemic regions. This will improve vaccine efficacy against various strains of a mutating virus to give a long lasting protection against multiple exposures to Ebola virus. In addition, our vaccine will not require storage at low temperatures (+4 to +8°C), overcoming the problems of stability, and storage in endemic regions, and allowing for ready deployment in the field.
ABACUS aims at a business-oriented and technology-driven development of a new algal biorefinery, thereby bringing to the market innovative algae-based ingredients for high-end applications, spanning from algal terpenes for fragrances to long-chain terpenoids (carotenoids) for nutraceuticals and cosmetic actives.
The project SUPER-RESOL aims at preparing the commercialization of a new, simple, and cheap, way of extracting super-resolution from images obtained with classical confocal fluorescence microscopy.
ZIKAlliance, a multinational and multi-disciplinary research consortium will investigate clinical, fundamental, environmental and social aspects of ZIKV infection. In particular, ZIKAlliance will focus on the impact of ZIKV infection during pregnancy and the natural history of ZIKV in humans and their environment. In collaboration with two other EC funded consortia (ZikaPLAN and ZIKAction), ZIKAlliance will also work on the development of a preparedness platform in Latin America and the Caribbean.
HARVEST (Marie Curie network formation ITN) of the light to harvest or the efficiency control of light utilization in plants and algae.
For information on European Affairs of the CEA's Fundamental Research Division see Section Europe DFS .
The teams of the institute maintain more than 150 international collaborations with leading research laboratories in the following countries: United States, Brazil, India, Canada, Japan ... For example, a delegation of experts from DSV conducted by its director, Gilles Bloch, participated in 2014 in Sao Paulo, to the workshop "Toxinology and Vaccines" organized jointly with the Butantan Institute (IBU) and the Faculty of Medicine of the University of Sao Paulo (USP). The IBU is a leading health and research actor in Brazil that provides a 90% share of Brazilian production of vaccines and anti-venoms and on the other hand, developing important research in the study and medical use of toxins. The IBITECS researchers, specialists in these fields, made the trip and the meeting ended with the signing of a Memorandum of Understanding (MoU) illustrating the will of Franco-Brazilian actors to structure their relationship in the long term.
For more information on DRF international collaborations consult our dedicated pages.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.